CME / CME Group Inc. (BMV) - Forecast, Price Target, Estimates, Predictions

CME Group Inc.
MX ˙ BMV ˙ US12572Q1058
Projected Stock Price
No data available.
Projected Revenue

1,608  MM ↓-4.78%

Estimated quarterly revenue by December 31, 2026.

Projected Earnings Per Share

2.99 ↑6.34%

Estimated quarterly earnings by December 31, 2027.

Price Target

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-03-05 2026-03-05 6,209.51 4,119.28 5,470.49 5,375.40
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for CME Group Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2024-07-10 Barclays Equal-Weight Equal-Weight Maintains
2024-07-09 Piper Sandler Overweight Overweight Maintains
2024-07-03 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-06-21 JP Morgan Neutral Underweight Downgrade
2024-04-25 JP Morgan Neutral Neutral Maintains
2024-04-25 B of A Securities Neutral Neutral Maintains
2024-04-25 Barclays Equal-Weight Equal-Weight Maintains
2024-04-25 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-04-25 Rosenblatt Sell Sell Reiterate
2024-04-09 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-04-08 Barclays Equal-Weight Equal-Weight Maintains
2024-04-05 Deutsche Bank Buy Hold Downgrade
2024-04-03 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-03-06 Argus Research Buy Buy Maintains
2024-02-15 Barclays Equal-Weight Equal-Weight Maintains
2024-01-08 Barclays Overweight Equal-Weight Downgrade
2024-01-04 Rosenblatt Sell Sell Reiterate
2024-01-03 Goldman Sachs Neutral Sell Downgrade
2023-10-26 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-10-26 Rosenblatt Sell Sell Maintains
2023-10-26 Barclays Overweight Overweight Maintains
2023-10-12 Citigroup Buy Buy Maintains
2023-10-11 JP Morgan Neutral Neutral Maintains
2023-10-11 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-10-11 Deutsche Bank Buy Buy Maintains
2023-10-10 Barclays Overweight Overweight Maintains
2023-10-04 Rosenblatt Sell Sell Reiterate
2023-09-06 B of A Securities Underperform Neutral Upgrade
2023-07-27 Citigroup Buy Buy Maintains
2023-07-27 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-07-27 Oppenheimer Outperform Outperform Reiterate
2023-07-27 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2023-07-27 Barclays Overweight Overweight Maintains
2023-07-27 Rosenblatt Sell Sell Maintains
2023-07-13 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-07-06 Citigroup Buy Buy Reiterate
2023-07-06 Rosenblatt Sell Sell Maintains
2023-06-28 Barclays Overweight Initiate
2023-04-19 JP Morgan Neutral Maintains
2023-04-12 Oppenheimer Outperform Maintains
2023-04-11 Morgan Stanley Equal-Weight Maintains
2023-04-05 Rosenblatt Sell Reiterate
2023-02-13 Morgan Stanley Equal-Weight Maintains
2023-02-09 Credit Suisse Outperform Maintains
2023-02-09 Rosenblatt Sell Reiterate
2023-02-07 Credit Suisse Outperform Maintains
2023-01-19 Oppenheimer Outperform Maintains
2023-01-11 Morgan Stanley Equal-Weight Maintains
2023-01-05 Credit Suisse Neutral Outperform Upgrade
2022-12-19 Piper Sandler Overweight Maintains
2022-10-27 Morgan Stanley Equal-Weight Maintains
2022-10-12 Deutsche Bank Hold Buy Upgrade
2022-10-12 Morgan Stanley Equal-Weight Maintains
2022-10-12 Citigroup Buy Initiate
2022-10-05 Rosenblatt Sell Maintains
2022-09-06 Credit Suisse Neutral Maintains
2022-08-17 Rosenblatt Sell Initiate
2022-08-15 Raymond James Outperform Market Perform Downgrade
2022-08-12 Deutsche Bank Hold Maintains
2022-08-03 Credit Suisse Neutral Maintains
2022-08-02 UBS Buy Maintains
2022-07-28 Morgan Stanley Equal-Weight Maintains
2022-07-28 Credit Suisse Neutral Maintains
2022-07-19 Morgan Stanley Equal-Weight Maintains
2022-07-13 Deutsche Bank Hold Maintains
2022-07-06 Raymond James Outperform Maintains
2022-07-06 UBS Buy Maintains
2022-07-06 Credit Suisse Neutral Maintains
2022-06-10 Atlantic Equities Neutral Overweight Upgrade
2022-06-03 UBS Buy Maintains
2022-05-25 Oppenheimer Perform Outperform Upgrade
2022-05-19 Deutsche Bank Hold Maintains
2022-05-16 Argus Research Hold Buy Upgrade
2022-04-28 Credit Suisse Neutral Maintains
2022-04-28 Citigroup Buy Maintains
2022-04-28 Rosenblatt Neutral Maintains
2022-04-28 Raymond James Outperform Maintains
2022-04-14 Rosenblatt Neutral Maintains
2022-04-13 Morgan Stanley Equal-Weight Maintains
2022-04-05 Credit Suisse Neutral Maintains
2022-03-08 Rosenblatt Neutral Maintains
2022-03-03 UBS Buy Maintains
2022-03-03 Credit Suisse Neutral Maintains
2022-02-15 Credit Suisse Neutral Initiate
2022-02-11 Morgan Stanley Equal-Weight Maintains
2022-02-10 Raymond James Outperform Maintains
2022-02-08 Atlantic Equities Overweight Neutral Downgrade
2022-01-20 Rosenblatt Sell Neutral Upgrade
2022-01-05 Raymond James Outperform Maintains
2021-10-28 Morgan Stanley Equal-Weight Maintains
2021-10-28 Rosenblatt Sell Maintains
2021-10-28 Raymond James Outperform Maintains
2021-10-08 Morgan Stanley Equal-Weight Maintains
2021-07-01 Morgan Stanley Equal-Weight Maintains
2021-06-14 Morgan Stanley Equal-Weight Initiate
2021-06-11 Morgan Stanley Equal-Weight Initiate
2021-06-10 Atlantic Equities Overweight Neutral Downgrade
2021-04-30 Argus Research Buy Hold Downgrade
2021-04-29 Citigroup Buy Maintains
2021-04-20 Citigroup Buy Maintains
2021-03-24 B of A Securities Neutral Buy Upgrade
2021-02-25 Wells Fargo Equal-Weight Overweight Upgrade
2021-02-11 Citigroup Buy Maintains
2021-01-15 Oppenheimer Outperform Perform Downgrade
2021-01-08 Deutsche bank Buy Hold Downgrade
2021-01-07 JP Morgan Underweight Neutral Upgrade
2021-01-06 Rosenblatt Sell Maintains
2020-12-03 Rosenblatt Sell Maintains
2020-11-04 Rosenblatt Sell Maintains
2020-10-29 Deutsche Bank Buy Maintains
2020-10-05 Rosenblatt Sell Maintains
2020-09-23 Atlantic Equities Neutral Overweight Upgrade
2020-09-10 Credit Suisse Neutral Maintains
2020-07-30 Deutsche Bank Buy Maintains
2020-07-30 Rosenblatt Sell Maintains
2020-07-13 Oppenheimer Outperform Maintains
2020-07-10 B of A Securities Neutral Maintains
2020-07-09 Deutsche Bank Buy Maintains
2020-06-23 Credit Suisse Neutral Maintains
2020-06-03 Rosenblatt Sell Maintains
2020-05-15 Deutsche Bank Buy Maintains
2020-04-30 Wells Fargo Equal-Weight Maintains
2020-04-30 UBS Buy Maintains
2020-04-29 CFRA Hold Maintains
2020-04-20 Citigroup Buy Maintains
2020-04-14 Keefe, Bruyette & Woods Market Perform Underperform Downgrade
2020-04-13 Oppenheimer Outperform Maintains
2020-04-09 Deutsche Bank Buy Maintains
2020-04-03 UBS Buy Maintains
2020-04-03 Citigroup Buy Maintains
2020-03-31 Deutsche Bank Buy Maintains
2020-03-30 Raymond James Market Perform Outperform Upgrade
2020-03-23 B of A Securities Neutral Maintains
2020-03-18 Deutsche Bank Buy Maintains
2020-03-05 Deutsche Bank Buy Maintains
2020-02-26 UBS Neutral Buy Upgrade
2020-02-13 CFRA Hold Maintains
2019-12-19 Deutsche Bank Buy Maintains
2019-12-16 Credit Suisse Neutral Initiate
2019-12-06 JP Morgan Underweight Maintains
2019-12-04 UBS Neutral Maintains
2019-11-27 Deutsche Bank Buy Maintains
2019-10-31 UBS Neutral Maintains
2019-10-31 Wells Fargo Market Perform Maintains
2019-10-21 Citigroup Buy Maintains
2019-10-03 UBS Neutral Maintains
2019-09-19 Berenberg Buy Hold Downgrade
2019-09-17 Oppenheimer Outperform Initiate
2019-09-05 UBS Neutral Maintains
2019-08-09 Deutsche Bank Buy Maintains
2019-07-03 Wells Fargo Market Perform Maintains
2019-07-03 UBS Neutral Maintains
2019-06-05 UBS Neutral Maintains
2019-05-02 UBS Neutral Neutral Maintains
2019-04-18 Rosenblatt Neutral Sell Downgrade
2019-03-26 Barclays Overweight Overweight Maintains
2019-03-15 Deutsche Bank Buy Buy Maintains
2019-02-15 JP Morgan Neutral Underweight Downgrade
2019-01-11 Bank of America Buy Neutral Downgrade
2018-11-28 Atlantic Equities Neutral Initiate
2018-11-28 UBS Buy Neutral Downgrade
2018-11-20 Berenberg Hold Buy Upgrade
2018-11-20 Citigroup Buy Buy Maintains
2018-11-16 Deutsche Bank Buy Buy Maintains
2018-10-26 Wells Fargo Market Perform Market Perform Maintains
2018-10-11 Deutsche Bank Buy Buy Maintains
2018-09-05 Rosenblatt Neutral Initiate
2018-07-10 Compass Point Neutral Initiate
2018-04-10 Bernstein Outperform Initiate
2018-04-06 Deutsche Bank Buy Buy Maintains
2018-03-08 Bank of America Buy Buy Maintains
2018-02-02 Barclays Overweight Overweight Maintains
2018-02-02 Bank of America Buy Buy Maintains
2018-01-25 Berenberg Hold Initiate
2017-10-19 Citigroup Buy Maintains
2017-10-10 Barclays Overweight Maintains
2017-10-04 Wells Fargo Market Perform Maintains
2017-09-08 Barclays Overweight Initiate
2017-09-06 UBS Buy Maintains
2017-07-17 Jefferies Buy Maintains
2017-07-12 Citigroup Buy Initiate
2016-11-14 JP Morgan Overweight Neutral Downgrade
2016-10-05 Deutsche Bank Buy Maintains
2016-08-31 Jefferies Buy Maintains
2016-08-05 Deutsche Bank Buy Maintains
2016-07-29 Keefe Bruyette & Woods Market Perform Maintains
2016-07-29 Barclays Equal-Weight Maintains
2016-07-29 Deutsche Bank Buy Maintains
2016-07-29 JP Morgan Overweight Maintains
2016-07-29 UBS Buy Maintains
2016-07-14 CLSA Underperform Maintains
2016-05-20 Sterne Agee CRT Neutral Initiate
2016-05-03 Buckingham Research Buy Initiate
2016-04-08 Keefe Bruyette & Woods Market Perform Maintains
2016-03-11 JP Morgan Neutral Maintains
2016-02-09 Deutsche Bank Buy Maintains
2016-02-08 Keefe Bruyette & Woods Market Perform Maintains
2016-01-26 Deutsche Bank Buy Maintains
2016-01-13 JP Morgan Neutral Overweight Upgrade
2016-01-06 Credit Suisse Neutral Maintains
2015-12-08 RBC Capital Underperform Initiate
2015-10-30 Barclays Equal-Weight Maintains
2015-10-08 Keefe Bruyette & Woods Market Perform Maintains
2015-09-04 JP Morgan Neutral Maintains
2015-08-11 Barclays Equal-Weight Maintains
2015-07-31 Keefe Bruyette & Woods Market Perform Maintains
2015-07-10 Barclays Equal-Weight Maintains
2015-07-06 UBS Buy Maintains
2015-06-17 Keefe Bruyette & Woods Market Perform Maintains
2015-06-05 JP Morgan Neutral Maintains
2015-05-08 Evercore ISI Group Hold Buy Upgrade
2015-05-08 Deutsche Bank Buy Maintains
2015-05-08 Barclays Equal-Weight Maintains
2015-05-01 Barclays Equal-Weight Maintains
2015-04-10 Barclays Equal-Weight Maintains
2015-03-30 Jefferies Buy Maintains
2015-03-06 Deutsche Bank Buy Maintains
2015-02-06 Deutsche Bank Buy Maintains
2015-02-06 Citigroup Buy Maintains
2015-01-23 Deutsche Bank Buy Maintains
2015-01-20 Citigroup Neutral Buy Upgrade
2015-01-07 Jefferies Buy Maintains
2015-01-07 CLSA Outperform Underperform Downgrade
2014-12-12 Deutsche Bank Buy Maintains
2014-12-08 Keefe, Bruyette & Woods Outperform Market Perform Downgrade
2014-10-31 Citigroup Neutral Maintains
2014-10-14 Deutsche Bank Buy Maintains
2014-10-08 Bank of America Neutral Maintains
2014-10-07 Citigroup Neutral Maintains
2014-10-02 Credit Suisse Neutral Maintains
2014-09-18 Keefe Bruyette & Woods Outperform Maintains
2014-09-10 Deutsche Bank Buy Initiate
2014-08-01 Barclays Equal-Weight Maintains
2014-07-08 JP Morgan Neutral Maintains
2014-06-30 Barclays Equal-Weight Maintains
2014-06-10 JP Morgan Neutral Maintains
2014-05-09 Jefferies Buy Maintains
2014-05-06 JP Morgan Neutral Maintains
2014-05-02 Barclays Equal-Weight Maintains
2014-05-02 UBS Buy Maintains
2014-05-02 Citigroup Hold Maintains
2014-04-10 Citigroup Neutral Maintains
2014-04-09 Citigroup Neutral Maintains
2014-01-28 JP Morgan Neutral Maintains
2014-01-08 Citigroup Buy Neutral Downgrade
2013-10-21 Compass Point Neutral Maintains
2013-09-25 Keefe Bruyette & Woods Market Perform Outperform Upgrade
2013-08-02 UBS Buy Maintains
2013-07-02 Raymond James Outperform Market Perform Downgrade
2013-06-25 JP Morgan Underweight Neutral Upgrade
2013-06-24 Goldman Sachs Sell Neutral Upgrade
2013-06-14 ISI Group Neutral Buy Upgrade
2013-06-04 Wells Fargo Market Perform Outperform Upgrade
2013-06-03 Jefferies Buy Maintains
2013-05-31 Keefe Bruyette & Woods Underperform Market Perform Upgrade
2013-05-21 Macquarie Outperform Neutral Downgrade
2013-05-03 Compass Point Neutral Maintains
2013-04-15 Jefferies Buy Maintains
2013-04-02 Credit Suisse Overweight Neutral Downgrade
2013-03-05 JP Morgan Underweight Maintains
2013-01-09 Compass Point Neutral Initiate
2012-12-14 Keefe Bruyette & Woods Market Perform Underperform Downgrade
2012-12-10 Goldman Sachs Neutral Sell Downgrade
2012-10-26 BGB Securities Hold Maintains
2012-10-26 UBS Buy Maintains
2012-10-26 Evercore Partners Overweight Equal-Weight Downgrade
2012-10-26 Raymond James Market Perform Outperform Upgrade
2012-10-08 Stifel Nicolaus Buy Hold Downgrade
2012-10-03 JP Morgan Underweight Maintains
2012-10-01 Jefferies Buy Maintains
2012-09-14 JP Morgan Neutral Underweight Downgrade
2012-08-17 UBS Neutral Maintains
2012-06-21 BGB Securities Hold Initiate
2012-04-27 UBS Buy Maintains
2012-04-27 ISI Group Hold Maintains
2012-04-27 JP Morgan Neutral Maintains
2012-04-27 Jefferies Buy Maintains
2012-04-12 Indaba Global Research Sell Initiate
2012-04-04 Jefferies Buy Maintains
2012-04-03 Deutsche Bank Hold Maintains
2012-03-20 UBS Buy Maintains
2012-03-16 Deutsche Bank Hold Maintains
2012-03-05 Evercore Partners Equal-Weight Maintains
2012-03-02 Stifel Nicolaus Buy Maintains
2024-09-27 RBC Capital Sector Perform Initiate
2024-09-26 TD Cowen Hold Initiate
2024-09-03 B of A Securities Neutral Underperform Downgrade
2024-07-25 Deutsche Bank Hold Hold Maintains
2024-07-25 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-07-25 JP Morgan Underweight Underweight Maintains
2024-07-25 Barclays Equal-Weight Equal-Weight Maintains
2024-07-25 Piper Sandler Overweight Overweight Maintains
2025-02-19 Morgan Stanley Equal-Weight Equal-Weight Maintains
2025-01-13 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-11-11 Deutsche Bank Hold Hold Maintains
2024-10-03 Goldman Sachs Sell Sell Maintains
2024-10-03 Citigroup Buy Buy Maintains
2024-10-03 RBC Capital Sector Perform Sector Perform Reiterate
2024-10-03 B of A Securities Underperform Underperform Maintains
2025-04-02 B of A Securities Underperform Underperform Maintains
2024-08-15 Deutsche Bank Hold Hold Maintains
2024-08-20 Piper Sandler Overweight Overweight Reiterate
2024-10-28 Piper Sandler Overweight Overweight Maintains
2024-10-24 RBC Capital Sector Perform Sector Perform Reiterate
2024-10-24 Oppenheimer Outperform Outperform Maintains
2024-10-24 Citigroup Buy Buy Maintains
2024-10-24 Barclays Equal-Weight Equal-Weight Maintains
2025-03-10 Raymond James Market Perform Outperform Upgrade
2025-04-11 Oppenheimer Outperform Outperform Maintains
2025-01-06 Citigroup Buy Neutral Downgrade
2024-12-20 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2024-12-09 Barclays Equal-Weight Equal-Weight Maintains
2025-02-14 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2025-02-13 JP Morgan Underweight Underweight Maintains
2025-02-13 Oppenheimer Outperform Outperform Maintains
2025-02-13 RBC Capital Sector Perform Sector Perform Maintains
2025-02-13 Barclays Equal-Weight Equal-Weight Maintains
2025-04-03 RBC Capital Sector Perform Sector Perform Reiterate
2025-04-24 JP Morgan Underweight Underweight Maintains
2025-04-24 Keefe, Bruyette & Woods Market Perform Market Perform Maintains
2025-04-24 Morgan Stanley Overweight Overweight Maintains
2025-04-23 Barclays Equal-Weight Equal-Weight Maintains
2025-06-04 Oppenheimer Outperform Outperform Maintains
2025-04-25 UBS Buy Buy Maintains
2024-10-17 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-10-14 Oppenheimer Outperform Outperform Maintains
2024-10-08 Redburn Atlantic Buy Neutral Downgrade
2024-10-08 Piper Sandler Overweight Overweight Maintains
2024-10-07 Barclays Equal-Weight Equal-Weight Maintains
2025-04-08 Piper Sandler Overweight Overweight Maintains
2025-04-07 Barclays Equal-Weight Equal-Weight Maintains
2025-01-07 Piper Sandler Overweight Overweight Maintains
2025-01-06 RBC Capital Sector Perform Sector Perform Reiterate
2025-07-24 Oppenheimer Outperform Outperform Maintains
2025-07-24 UBS Buy Neutral Downgrade
2025-07-24 Barclays Equal-Weight Equal-Weight Maintains
2025-07-03 Citigroup Neutral Neutral Maintains
2025-07-10 Barclays Equal-Weight Equal-Weight Maintains
2025-07-15 Piper Sandler Overweight Overweight Maintains
Revenue Estimates

The forecasted annual revenue of CME Group Inc. in 2028-12-31 is 6,899MM. )

Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.

However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.

How to Interpret Revenue Estimates?

Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.

Update Frequency: Quarterly

Date Revenue Average Quarterly (MM) Number of Analysts (Quarterly) Revenue Average Annually (MM) Number of Analysts (Annually)
2025-09-30 1,469 2 -- --
2025-12-31 1,457 2 5,904 10
2026-03-31 1,663 2 -- --
2026-06-30 1,609 2 -- --
2026-09-30 1,626 2 -- --
2026-12-31 1,608 2 6,103 3
2027-12-31 -- -- 6,361 3
2028-12-31 -- -- 6,899 3
Earnings Estimates

The forecasted annual earnings of CME Group Inc. in 2029-12-31 is 13.69 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 2.28 2 -- --
2025-12-31 2.17 2 9.50 10
2026-03-31 2.70 2 -- --
2026-06-30 2.56 2 -- --
2026-09-30 2.60 2 -- --
2026-12-31 2.52 2 10.05 2
2027-03-31 3.21 5 -- --
2027-06-30 3.26 5 -- --
2027-09-30 3.07 5 -- --
2027-12-31 2.99 5 11.06 2
2028-12-31 -- -- 11.46 2
2029-12-31 -- -- 13.69 2
EBITDA Estimates

The forecasted annual EBITDA of CME Group Inc. in 2028-12-31 is 5,000MM.

EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

EBITDA vs. Net Income

Net income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.

Update Frequency: Quarterly

Date EBITDA Average (MM Quarterly) Number of Analysts (Quarterly) EBITDA Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
2027-12-31
2028-12-31
EBIT Estimates

The forecasted annual EBIT of CME Group Inc. in 2028-12-31 is 4,870MM.

EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.

EBIT vs. EBITDA

EBITDA also strips out depreciation and amortization from a company’s earnings:

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

Update Frequency: Quarterly

Date EBIT Average (MM Quarterly) Number of Analysts (Quarterly) EBIT Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
2027-12-31
2028-12-31
Other Listings
BG:MX4A
US:CME $261.94
GB:0HR2 $261.31
IT:1CME €228.65
AT:CMEG
DE:MX4A €228.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista